AR117590A1 - Extracto y composición dermatológica que lo comprende para el tratamiento de piel sensible - Google Patents
Extracto y composición dermatológica que lo comprende para el tratamiento de piel sensibleInfo
- Publication number
- AR117590A1 AR117590A1 ARP190101482A ARP190101482A AR117590A1 AR 117590 A1 AR117590 A1 AR 117590A1 AR P190101482 A ARP190101482 A AR P190101482A AR P190101482 A ARP190101482 A AR P190101482A AR 117590 A1 AR117590 A1 AR 117590A1
- Authority
- AR
- Argentina
- Prior art keywords
- liquid phase
- extract
- liquid
- phase
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Reivindicación 1: Extracto bacteriano de una bacteria Gram-negativa no patogénica perteneciente a la clase Betaproteobacteria, subfamilia Neisseriaceae, que comprende un ARNr 16S que comprende la secuencia SEQ ID Nº 1, o cualquier secuencia que tiene por lo menos 80% de identidad con la secuencia SEQ ID Nº 1, dicho extracto bacteriano se obtiene, o puede obtenerse, mediante un proceso que comprende las siguientes etapas: a) cultivo de dicha bacteria en un medio adecuado para obtener un cultivo bacteriano, b) separación líquido / sólido de dicho cultivo y remoción de la fase líquida; c) lisis celular de la fase sólida, d) resuspensión de la fase sólida lisada en una fase líquida acuosa, preferentemente tamponada, e) separación líquido / sólido y recuperación de la fase líquida, f) filtración opcional de la fase líquida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1854794A FR3081705B1 (fr) | 2018-06-01 | 2018-06-01 | Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR117590A1 true AR117590A1 (es) | 2021-08-18 |
Family
ID=63407394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190101482A AR117590A1 (es) | 2018-06-01 | 2019-05-31 | Extracto y composición dermatológica que lo comprende para el tratamiento de piel sensible |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11857578B2 (es) |
| EP (1) | EP3801580B1 (es) |
| JP (1) | JP7357645B2 (es) |
| KR (1) | KR20210015871A (es) |
| CN (1) | CN112423769A (es) |
| AR (1) | AR117590A1 (es) |
| AU (1) | AU2019276356A1 (es) |
| BR (1) | BR112020023771A2 (es) |
| CA (1) | CA3100594A1 (es) |
| ES (1) | ES2964122T3 (es) |
| FR (1) | FR3081705B1 (es) |
| MX (1) | MX2020012882A (es) |
| SG (1) | SG11202011861RA (es) |
| WO (1) | WO2019229248A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102621138B1 (ko) | 2023-05-12 | 2024-01-05 | 주식회사 포레스트에비뉴 | 시트프리 거품형 마스크팩 조성물 및 이를 활용한 거품형 마스크팩 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2918884B1 (fr) * | 2007-07-17 | 2010-01-15 | Oreal | Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur |
| FR2920305B1 (fr) * | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
| FR2969657B1 (fr) * | 2010-12-22 | 2014-02-07 | Fabre Pierre Dermo Cosmetique | Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie |
| FR2969658B1 (fr) * | 2010-12-22 | 2014-10-17 | Fabre Pierre Dermo Cosmetique | Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique |
| EP3538117A1 (en) * | 2016-11-10 | 2019-09-18 | Allergan, Inc. | Methods for alleviating histamine-independent pruritus using neurotoxins |
| FR3065009B1 (fr) * | 2017-04-06 | 2020-11-27 | Fabre Pierre Dermo Cosmetique | Secretome bacterien pour son utilisation dans le traitement des lesions cutanees |
-
2018
- 2018-06-01 FR FR1854794A patent/FR3081705B1/fr active Active
-
2019
- 2019-05-31 WO PCT/EP2019/064211 patent/WO2019229248A1/fr unknown
- 2019-05-31 ES ES19734252T patent/ES2964122T3/es active Active
- 2019-05-31 AU AU2019276356A patent/AU2019276356A1/en active Pending
- 2019-05-31 US US17/059,810 patent/US11857578B2/en active Active
- 2019-05-31 CA CA3100594A patent/CA3100594A1/fr active Pending
- 2019-05-31 BR BR112020023771-0A patent/BR112020023771A2/pt unknown
- 2019-05-31 SG SG11202011861RA patent/SG11202011861RA/en unknown
- 2019-05-31 MX MX2020012882A patent/MX2020012882A/es unknown
- 2019-05-31 EP EP19734252.0A patent/EP3801580B1/fr active Active
- 2019-05-31 CN CN201980035558.4A patent/CN112423769A/zh active Pending
- 2019-05-31 AR ARP190101482A patent/AR117590A1/es unknown
- 2019-05-31 JP JP2020566988A patent/JP7357645B2/ja active Active
- 2019-05-31 KR KR1020207036864A patent/KR20210015871A/ko active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020023771A2 (pt) | 2021-03-23 |
| EP3801580B1 (fr) | 2023-08-30 |
| CA3100594A1 (fr) | 2019-12-05 |
| WO2019229248A1 (fr) | 2019-12-05 |
| US11857578B2 (en) | 2024-01-02 |
| EP3801580A1 (fr) | 2021-04-14 |
| MX2020012882A (es) | 2021-02-18 |
| KR20210015871A (ko) | 2021-02-10 |
| FR3081705A1 (fr) | 2019-12-06 |
| US20210353690A1 (en) | 2021-11-18 |
| SG11202011861RA (en) | 2020-12-30 |
| JP2021526373A (ja) | 2021-10-07 |
| ES2964122T3 (es) | 2024-04-04 |
| JP7357645B2 (ja) | 2023-10-06 |
| CN112423769A (zh) | 2021-02-26 |
| AU2019276356A1 (en) | 2020-12-17 |
| FR3081705B1 (fr) | 2020-12-04 |
| EP3801580C0 (fr) | 2023-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201806217UA (en) | Culture medium composition | |
| CO2019001319A2 (es) | Metodo y sistema para farmacogenómica microbiana | |
| CL2019002641A1 (es) | Composiciones y métodos que involucran moléculas probióticas. | |
| AR117590A1 (es) | Extracto y composición dermatológica que lo comprende para el tratamiento de piel sensible | |
| MX2018000840A (es) | Concentracion, recuperacion y deteccion rapida de patogenos en muestras de alimentos. | |
| ECSP22045408A (es) | Bacterias productoras de serotonina | |
| Massoudian et al. | Absence of Helicobacter pylori in the river waters in the north of Iran | |
| BR112023005111A2 (pt) | Método para recuperar uma proteína de interesse de um caldo de fermentação bacteriana, e, uso de pelo menos um floculante | |
| Mullen et al. | 4.6 Microbiota transplantation for equine colitis: revisiting an old treatment with new technology | |
| Saleh et al. | ISOLATION AND MOLECULAR IDENTIFICATION OF BASILLUS PUMILUS FROM WOUND INFECTION FOR THE FIRST TIME IN IRAN | |
| Yogeswaran et al. | Determination of optimum dilutions of extracted antigens from Burkholderiapseudomallei strains of Sri Lankan origin for the diagnosis of melioidosis using the indirect hemagglutination assay (IHA) | |
| Moshynets et al. | Extraction and identification of endophytic bacteria from bamboo plants (** Phyllostachys** and** Fargesia**) | |
| CO2024007501A2 (es) | Composiciones y métodos para expresar antígenos en la membrana celular | |
| Asghari et al. | THE PREVALENCE OF ESCHERICHIA COLI STRAINS HARBORING IPAH VIRULENCE GENE ISOLATED FROM SURFACE WATER SOURCES OF TEHRAN PROVINCE | |
| Sadrinia et al. | AN EVALUATION AND COMPARISON OF ANTIBACTERIAL EFFECTS OF HUMAN AMNIOTIC MEMBRANES AND THE AMNIOTIC FLUID IN VITRO | |
| Aghaei et al. | ISOLATION AND MOLECULAR IDENTIFICATION OF NATIVE RHODOCOCCUS STRAINS FROM MANGANESE MINE SOIL IN QOM CITY | |
| Kojouri et al. | ISOLATION, IDENTIFICATION OF XANTHOMONAS STRAIN FROM LEAVES OF LEMON TREES AND STUDYING THE PRODUCTION OF XANTHAN GUM | |
| Ainiao et al. | Research of “Project-driven” Experimental Teaching Mode in Economics and Management Specialty | |
| AR122233A1 (es) | Medio de cultivo para bacterias y procedimiento para su elaboración | |
| Aly | T HE RELATIONSHIP BETWEEN SALTS AND GROWTH OF STREPTOMYCES COLONIES ISOLATED FROM MURAL PAINTINGS IN ANCIENT EGYPTIAN TOMBS | |
| SAIDI | ANTIBACTERIAL ACTIVITY IN LOCAL Chromolaena odorata | |
| Al-Difaie | Identification of cryptosporidium parvum parasite oocyst using microscopic &PCR assay for detection GP900gene | |
| CL2020001958A1 (es) | Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas. | |
| Panda | 2.2 Traditional culture methods | |
| Andrew et al. | Near-Complete Genome Sequence of Clostridium paradoxum Strain JW-YL-7 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |